Author:
Saeki Toshiaki,Takashima Shigemitsu,Ogita Masami,Tabei Toshio,Adachi Isamu,Tamura Kazuo,Takatsuka Yuichi,Kanda Kazuhiro
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference14 articles.
1. Bull JM, Tormey DC, Li SH,et al: A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer 41:1649–1657, 1978.
2. Tranum B, Hoogstraten B, Kennedy A,et al: Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study. Cancer 41:2078–2083, 1978.
3. Aisner J, Weinberg V, Perloff M,et al: Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/− MER) for metastic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. J.Clin.Oncol 5:1523–1533, 1987.
4. Watanabe T, Adachi I, Tajima K,et al. Improving the quality of life during chemoendocrine therapy for metastatic breast cancer: A randomized comparison of tamoxifen (TAM) versus medroxyprogestron acetate (MPA) in combination with doxorubicin (ADM) plus cyclophosphamide (CPA). Proc. Ann. Soc. Clin. Oncol 12, abstract 90, 1994.
5. Spielman M, Dorval T, Turpin F,et al: Phase II trial of VNB/doxorubicin as first-line therapy of advanced breast cancer. J Clin Oncol 12:1764–1770, 1994.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献